Yoshitane Nozaki

1.5k citations

26 papers · 1.3k indexed · h-index 16

Oncology top 5%
Pediatrics, Perinatology and Child Health top 2%
Pharmacology top 1%
Molecular Biology
Endocrinology, Diabetes and Metabolism top 10%

Co-authors: Hiroyuki Kusuhara Yuichi Sugiyama Kazuya Maeda Saki Izumi Osamu Takenaka Takafumi Komori Masaru Hirano Soichiro Matsushima
Topics: Drug Transport and Resistance Mechanisms (22 papers)Pharmacological Effects and Toxicity Studies (15 papers)Pharmacogenetics and Drug Metabolism (6 papers)
Cited by: Pharmacology Oncology Pediatrics, Perinatology and Child Health
Journals: Journal of Biological Chemistry Journal of Pharmacology and Experimental Therapeutics Molecular Pharmacology
Partner nations: Japan Switzerland South Korea

In The Last Decade

Yoshitane Nozaki

23 papers receiving 1.2k citations

Peers

Countries citing papers authored by Yoshitane Nozaki

Since Specialization

Citations

This map shows the geographic impact of Yoshitane Nozaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshitane Nozaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshitane Nozaki more than expected).

Fields of papers citing papers by Yoshitane Nozaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshitane Nozaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshitane Nozaki. The network helps show where Yoshitane Nozaki may publish in the future.

Co-authorship network of co-authors of Yoshitane Nozaki

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshitane Nozaki. A scholar is included among the top collaborators of Yoshitane Nozaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshitane Nozaki. Yoshitane Nozaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quantitative analysis of coproporphyrin and its precursors as endogenous biomarkers for drug–drug interactions involving OATP1B1 and OATP1B3 in monkeys 2025 ·Drug Metabolism and Disposition ·Saki Izumi,(unknown),(unknown),Yoshitane Nozaki,Hiroyuki Kusuhara	0
2	In vitro–in vivo scaling of cytochrome P450-mediated metabolic clearance using a relative activity factor approach 2025 ·Drug Metabolism and Disposition ·(unknown),Yoshitane Nozaki	0
3	Influence of the genetic polymorphism of CYP2D1 on metabolism and pharmacokinetics of E2027 in rats 2025 ·Drug Metabolism and Pharmacokinetics ·(unknown),Masae Yamamoto,(unknown),Koji Sagane,(unknown),Yosuke Nakatani,Yoshitane Nozaki	0
4	Comparative sensitivity of laboratory animals used for preclinical convulsion risk assessment to drug-induced convulsion 2024 ·The Journal of Toxicological Sciences ·(unknown),(unknown),M. Takano,Hiroki Ishihara,(unknown),Yoshitane Nozaki,(unknown),Tomohiko Taniguchi,Norimasa Miyamoto,Takashi Yoshinaga,Shoji Asakura	1
5	Preincubation Time-Dependent, Long-Lasting Inhibition of Drug Transporters and Impact on the Prediction of Drug−Drug Interactions 2023 ·Drug Metabolism and Disposition ·Yoshitane Nozaki,Saki Izumi	15
6	Experimental and Modeling Evidence Supporting the Trans-Inhibition Mechanism for Preincubation Time-Dependent, Long-Lasting Inhibition of Organic Anion Transporting Polypeptide 1B1 by Cyclosporine A 2022 ·Drug Metabolism and Disposition ·Saki Izumi,Yoshitane Nozaki,Wooin Lee,Yuichi Sugiyama	20
7	Functional Investigation of Solute Carrier Family 35, Member F2, in Three Cellular Models of the Primate Blood-Brain Barrier 2020 ·Drug Metabolism and Disposition ·Tatsuki Mochizuki,Tadahaya Mizuno,Toshiki Kurosawa,Tomoko Yamaguchi,Kei Higuchi,Yuma Tega,Yoshitane Nozaki,Kenji Kawabata,Yoshiharu Deguchi,Hiroyuki Kusuhara	14
8	Alteration in the Plasma Concentrations of Endogenous Organic Anion–Transporting Polypeptide 1B Biomarkers in Patients with Non–Small Cell Lung Cancer Treated with Paclitaxel 2020 ·Drug Metabolism and Disposition ·Daiki Mori,Hiroo Ishida,Tadahaya Mizuno,Sojiro Kusumoto,Yusuke Kondo,Saki Izumi,(unknown),Yoshitane Nozaki,Kazuya Maeda,Yasutsuna Sasaki,Ken‐ichi Fujita,Hiroyuki Kusuhara	29
9	Impact of P-Glycoprotein–Mediated Active Efflux on Drug Distribution into Lumbar Cerebrospinal Fluid in Nonhuman Primates 2020 ·Drug Metabolism and Disposition ·(unknown),(unknown),Hiroyuki Kusuhara,Yoshitane Nozaki	12
10	Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters 2019 ·Drug Metabolism and Pharmacokinetics ·Yoshitane Nozaki,Saki Izumi	16
11	Relative Activity Factor (RAF)-Based Scaling of Uptake Clearance Mediated by Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 in Human Hepatocytes 2018 ·Molecular Pharmaceutics ·Saki Izumi,Yoshitane Nozaki,Hiroyuki Kusuhara,(unknown),(unknown),Takafumi Komori,Kazuya Maeda,Yuichi Sugiyama	34
12	Comparison of the Predictability of Human Hepatic Clearance for Organic Anion Transporting Polypeptide Substrate Drugs Between Different In Vitro–In Vivo Extrapolation Approaches 2017 ·Journal of Pharmaceutical Sciences ·Saki Izumi,Yoshitane Nozaki,Takafumi Komori,Osamu Takenaka,Kazuya Maeda,Hiroyuki Kusuhara,Yuichi Sugiyama	41
13	Investigation of utility of cerebrospinal fluid drug concentration as a surrogate for interstitial fluid concentration using microdialysis coupled with cisternal cerebrospinal fluid sampling in wild-type and Mdr1a(−/−) rats 2015 ·Drug Metabolism and Pharmacokinetics ·(unknown),Yoshitane Nozaki,Osamu Takenaka,(unknown),Kazutomi Kusano,Tsutomu Yoshimura,Hiroyuki Kusuhara	12
14	Utility of Cerebrospinal Fluid Drug Concentration as a Surrogate for Unbound Brain Concentration in Nonhuman Primates 2014 ·Drug Metabolism and Pharmacokinetics ·(unknown),Yoshitane Nozaki,(unknown),Osamu Takenaka,Yosuke Nakatani,Kazutomi Kusano,Tsutomu Yoshimura,Hiroyuki Kusuhara	29
15	Substrate-Dependent Inhibition of Organic Anion Transporting Polypeptide 1B1: Comparative Analysis with Prototypical Probe Substrates Estradiol-17β-Glucuronide, Estrone-3-Sulfate, and Sulfobromophthalein 2013 ·Drug Metabolism and Disposition ·Saki Izumi,Yoshitane Nozaki,Takafumi Komori,Kazuya Maeda,Osamu Takenaka,Kazutomi Kusano,Tsutomu Yoshimura,Hiroyuki Kusuhara,Yuichi Sugiyama	84
16	Species Difference in the Inhibitory Effect of Nonsteroidal Anti-Inflammatory Drugs on the Uptake of Methotrexate by Human Kidney Slices 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Yoshitane Nozaki,Hiroyuki Kusuhara,Tsunenori Kondo,Masahiro Iwaki,Yoshiyuki Shiroyanagi,Hideki Nakayama,Shigeru Horita,Hayakazu Nakazawa,Teruo Okano,Yuichi Sugiyama	120
17	Characterization of the Uptake of Organic Anion Transporter (OAT) 1 and OAT3 Substrates by Human Kidney Slices 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Yoshitane Nozaki,Hiroyuki Kusuhara,Tsunenori Kondo,Maki Hasegawa,Yoshiyuki Shiroyanagi,Hayakazu Nakazawa,Teruo Okano,Yuichi Sugiyama	86
18	FUNCTIONAL INVOLVEMENT OF RAT ORGANIC ANION TRANSPORTER 2 (SLC22A7) IN THE HEPATIC UPTAKE OF THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG KETOPROFEN 2005 ·Drug Metabolism and Disposition ·(unknown),Hiroyuki Kusuhara,Yoshitane Nozaki,Hitoshi Endou,Yuichi Sugiyama	19
19	Involvement of BCRP (ABCG2) in the Biliary Excretion of Pitavastatin 2005 ·Molecular Pharmacology ·Masaru Hirano,Kazuya Maeda,Soichiro Matsushima,Yoshitane Nozaki,Hiroyuki Kusuhara,Yuichi Sugiyama	212
20	Quantitative Evaluation of the Drug-Drug Interactions between Methotrexate and Nonsteroidal Anti-Inflammatory Drugs in the Renal Uptake Process Based on the Contribution of Organic Anion Transporters and Reduced Folate Carrier 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Yoshitane Nozaki,Hiroyuki Kusuhara,Hitoshi Endou,Yuichi Sugiyama	61

About Yoshitane Nozaki

Yoshitane Nozaki is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (22 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Pharmacogenetics and Drug Metabolism (6 papers). The work is most often cited by research in Pharmacology (336 citations), Oncology (902 citations) and Pediatrics, Perinatology and Child Health (497 citations). Yoshitane Nozaki has collaborated with scholars based in Japan, Switzerland and South Korea. Frequent co-authors include Hiroyuki Kusuhara, Yuichi Sugiyama, Kazuya Maeda, Saki Izumi, Osamu Takenaka, Takafumi Komori, Masaru Hirano, Soichiro Matsushima, Hiroyuki Aburatani and Daisuke Sugiyama. Their work appears in journals such as Journal of Biological Chemistry, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact